Insilico Medicine
Generative AI software for drug discovery
Insilico Medicine is a biotechnology company that uses generative artificial intelligence to transform drug discovery. It aims to extend healthy longevity by significantly reducing the time and cost of developing new medications.
| Best for | pharmaceutical research teams |
| Website | insilico.com |
Strengths and trade-offs
- The AI tool discovers and prioritises novel therapeutic targets using PandaOmics.
- The AI tool generates novel molecules through its Chemistry42 platform.
Appears in
Alternatives to Insilico Medicine
Pioneering motion-based drug design through protein dynamics | #1 in Best AI drug discovery platforms | 80.0 |
Opening new worlds for molecular discovery | #2 in Best AI drug discovery platforms | 80.0 |
This is drug discovery re-imagined | #3 in Best AI drug discovery platforms | 80.0 |
Pioneering AI and robotics in drug discovery | #4 in Best AI drug discovery platforms | 78.0 |
A lab without limits for biopharma discovery | #6 in Best AI drug discovery platforms | 78.0 |
Inventing new Drugs at scale with AI and physics | #7 in Best AI drug discovery platforms | 76.0 |
Questions about Insilico Medicine
Who is Insilico Medicine best for?
Insilico Medicine is best for pharmaceutical research teams.
Where does Insilico Medicine rank?
Insilico Medicine is ranked #5 in Best AI drug discovery platforms (Lister Score 78.0).
What are the best alternatives to Insilico Medicine?
The closest alternatives on Lister are Relay Therapeutics (#1 in Best AI drug discovery platforms), Schrödinger (#2 in Best AI drug discovery platforms) and Valo Health (#3 in Best AI drug discovery platforms).
Is this your company?
Claim Insilico Medicine to suggest corrections to its listing (pricing, features, details) or ask about an enhanced profile. We review every claim before anything changes.